Statistics
Publications
9
Citations
1.4K
H-Index
9
Active since
2013
Ali Farsidjani is an author at Novartis (Switzerland) specializing in molecular oncology, pharmacology, and pharmacy.
Publications per year
2013–2023
9
9
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
Huai‐Xiang Hao, Hongyun Wang, Chen Liu et al. · Molecular Cancer Therapeutics · 2019 · 54 citations
Medicine, Oncology, Pharmacology +17
1–5 of 9